4.7 Review

Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences

期刊

出版社

MDPI
DOI: 10.3390/ijms22126551

关键词

COVID-19; SARS-CoV-2; estrogen; estrogen receptor; viral replication; IL-6; cytokine storm

资金

  1. Ministry of Education, Youth and Sport of the Czech Republic [CZ.02.1.01/0.0/0.0/16_019/0000785]
  2. Charles University [PROGRES Q28]

向作者/读者索取更多资源

Estrogens may have a protective effect against COVID-19 by influencing the cardiovascular/pulmonary/immune system, reducing cytokine storms, and directly inhibiting viral replication. In addition to natural hormones, phytestrogens and synthetic molecules may also have anti-viral activity.
COVID-19 is a pandemic respiratory disease caused by the SARS-CoV-2 coronavirus. The worldwide epidemiologic data showed higher mortality in males compared to females, suggesting a hypothesis about the protective effect of estrogens against severe disease progression with the ultimate end being patient's death. This article summarizes the current knowledge regarding the potential effect of estrogens and other modulators of estrogen receptors on COVID-19. While estrogen receptor activation shows complex effects on the patient's organism, such as an influence on the cardiovascular/pulmonary/immune system which includes lower production of cytokines responsible for the cytokine storm, the receptor-independent effects directly inhibits viral replication. Furthermore, it inhibits the interaction of IL-6 with its receptor complex. Interestingly, in addition to natural hormones, phytestrogens and even synthetic molecules are able to interact with the estrogen receptor and exhibit some anti-COVID-19 activity. From this point of view, estrogen receptor modulators have the potential to be included in the anti-COVID-19 therapeutic arsenal.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据